U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H13NO2.ClH
Molecular Weight 203.666
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 3-O-METHYLDOPAMINE HYDROCHLORIDE

SMILES

Cl.COC1=C(O)C=CC(CCN)=C1

InChI

InChIKey=AWRIOTVUTPLWLF-UHFFFAOYSA-N
InChI=1S/C9H13NO2.ClH/c1-12-9-6-7(4-5-10)2-3-8(9)11;/h2-3,6,11H,4-5,10H2,1H3;1H

HIDE SMILES / InChI
3-Methoxytyramine (3-MT) is a human trace amine that occurs as a metabolite of the neurotransmitter dopamine. It has been shown to act as an agonist of human TAAR1, and an inhibitor of mitochondrial respiration. 3-MT has garnered research interest for its potential links and implications to Parkinson's disease and other Neurological disorders.

CNS Activity

Curator's Comment: CNS Active; but limited capacity to penetrate BBB.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q96RJ0
Gene ID: 134864.0
Gene Symbol: TAAR1
Target Organism: Homo sapiens (Human)
700.0 nM [EC50]
19.6 mM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Melanoma detection by enzyme-radioimmunoassay of L-dopa, dopamine, and 3-O-methyldopamine in urine.
1981 Jan
Postmortem accumulation of 3-methoxytyramine in the brain.
1984 Aug 23
Analysis of S-nitroso-N-acetylpenicillamine effects on dopamine release in the striatum of freely moving rats: role of endogenous ascorbic acid and oxidative stress.
2001 Feb
Determination of catecholamines and metanephrines in urine by capillary electrophoresis-electrospray ionization-time-of-flight mass spectrometry.
2002 Sep 5
Assessment of O-methylated catecholamine levels in plasma and urine for diagnosis of autonomic disorders.
2004 Nov 30
Isolation and identification of phase II enzyme-inducing agents from nonpolar extracts of green onion (Allium spp.).
2006 Nov 1
Further evidence for aberrant prefrontal salience coding in schizophrenia.
2010
Low penetrance of a SDHB mutation in a large Dutch paraganglioma family.
2010 Jun 11
Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice.
2010 Jun 8
In utero exposure to a low concentration of diesel exhaust affects spontaneous locomotor activity and monoaminergic system in male mice.
2010 Mar 23
Attenuation of circulatory shock and cerebral ischemia injury in heat stroke by combination treatment with dexamethasone and hydroxyethyl starch.
2010 Oct 11
Patents

Sample Use Guides

Locomotor activity of DAT-KO and WT mice was measured in an Omnitech CCDigiscan. To assess effects of 3-MT in normal and TAAR1-KO mice, the animals were placed in the locomotor activity chamber and 30 min later various doses of 3-MT were administered i.c.v. over 4 minutes. After infusion, animals were put back into experimental chamber and behavior was monitored for 90 min after administration. 3-MT induced significant behavioral activation in DDD mice. Striatal tissue was collected from DDD mice treated with 36 µg of 3-MT 30 minutes after administration was analyzed for ERK activity. 3-MT caused a significant increase in the level of phosphorylated Erk2, thus indicating that certain receptor-mediated processes in striatal cells are affected by this treatment.
Route of Administration: Other
Mitochondria were isolated from whole brains of Sprague-Dawley rats. Mitochondria were suspended in 1 mL of incubation buffer containing 0.095MKCl, 0.075Mmannitol,0.025Msucrose, 0.005MKH2PO4, 0.020MTris-HCl, 0.001MEGTA, pH 7.4 (adjusted with KOH) at a final concentration of between 0.40 and 0.80 mg protein/mL. Malate and pyruvate were added to a final concentration of 10 mM. Oxygen consumption was carried out at 30°C in a closed chamber containing a Clark type oxygen electrode connected to a YSI model5300 oxygen monitor. Following a 10-minute incubation, resting conditions (no ADP) were monitored for 5 minutes, followed by the addition of ADP (0.25 mMfinal concentration) and measurement of active respiration. ADP depleted respiration was also monitored. Pre-incubation with the mitochondrial inhibitor 3-Methoxytyramine (3-MT) was carried out for15 min at 30°C prior to addition of ADP. Incubation with 3-MT was carried out in the dark for the first 10 minutes. IC50measurements represent the millimolar concentration of inhibitor required to inhibit 50% malate/pyruvate supported respiration compared with controls containing no inhibitor following a 15-min incubation at 30°C. 3-MT was found to inhibit brain mitochondrial respiration by MAO-dependent and -independent mechanisms. The IC50 of mitochondrial respiratory inhibition for 3-MT was determined to be 19.6 mM.
Name Type Language
3-O-METHYLDOPAMINE HYDROCHLORIDE
Systematic Name English
4-HYDROXY-3-METHOXYPHENETHYLAMINE HYDROCHLORIDE
Systematic Name English
NSC-172190
Code English
2-METHOXYTYRAMINE HYDROCHLORIDE
Systematic Name English
4-HYDROXY-3-METHOXY-.BETA.-PHENETHYLAMINE HYDROCHLORIDE
Systematic Name English
4-(2-AMINOETHYL)-2-METHOXYPHENOL HYDROCHLORIDE
Systematic Name English
DOPAMINE RELATED COMPOUND B [USP-RS]
Common Name English
GUAIACOL, 4-(2-AMINOETHYL)-, HYDROCHLORIDE
Systematic Name English
3-METHOXY-4-HYDROXYPHENETHYLAMINE HYDROCHLORIDE
Systematic Name English
PHENOL, 4-(2-AMINOETHYL)-2-METHOXY-, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
216-035-1
Created by admin on Fri Dec 15 19:50:37 GMT 2023 , Edited by admin on Fri Dec 15 19:50:37 GMT 2023
PRIMARY
NSC
172190
Created by admin on Fri Dec 15 19:50:37 GMT 2023 , Edited by admin on Fri Dec 15 19:50:37 GMT 2023
PRIMARY
EPA CompTox
DTXSID40163784
Created by admin on Fri Dec 15 19:50:37 GMT 2023 , Edited by admin on Fri Dec 15 19:50:37 GMT 2023
PRIMARY
RS_ITEM_NUM
1225226
Created by admin on Fri Dec 15 19:50:37 GMT 2023 , Edited by admin on Fri Dec 15 19:50:37 GMT 2023
PRIMARY
FDA UNII
95HIL684P5
Created by admin on Fri Dec 15 19:50:37 GMT 2023 , Edited by admin on Fri Dec 15 19:50:37 GMT 2023
PRIMARY
CAS
1477-68-5
Created by admin on Fri Dec 15 19:50:37 GMT 2023 , Edited by admin on Fri Dec 15 19:50:37 GMT 2023
PRIMARY
RXCUI
1741053
Created by admin on Fri Dec 15 19:50:37 GMT 2023 , Edited by admin on Fri Dec 15 19:50:37 GMT 2023
PRIMARY
DAILYMED
95HIL684P5
Created by admin on Fri Dec 15 19:50:37 GMT 2023 , Edited by admin on Fri Dec 15 19:50:37 GMT 2023
PRIMARY
PUBCHEM
11356165
Created by admin on Fri Dec 15 19:50:37 GMT 2023 , Edited by admin on Fri Dec 15 19:50:37 GMT 2023
PRIMARY